University of North Carolina, Chapel Hill
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of North Carolina, Chapel Hill sits in the top decile of US sponsors by registered trial count (#28 of 15,742 sponsors by registered trial count).
University of North Carolina, Chapel Hill: 1,109 sponsored US clinical trials, 108 recruiting.
University of North Carolina, Chapel Hill sponsors 1,109 registered US clinical trials on ClinicalTrials.gov, 108 of them currently recruiting, and 881 completed. 69 of these trials are in Phase 3-4 (later-stage) and 203 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 17 trials.
Top-decile sponsor footprint
University of North Carolina, Chapel Hill ranks in the top decile of sponsors by registered trial count (#28 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
881 of 962 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,109 total, page 18 of 23
The Influence of Beta Blocker Therapy on the Hemodynamic Response to Inotrope Infusion in Patients With Acute Decompensated Heart Failure
NCT01971944
Testing the Efficacy of an Online Social Network Intervention to Increase Social Support for Physical Activity
NCT01421758
Human Cytochrome P450 4F Enzymes and Drug Interactions
NCT01250535
Decision Support Interventions (DESI) for Prostate Cancer Screening and Treatment - Study 2
NCT01244568
Peanut Oral Immunotherapy (OIT) - Initial Pilot Study in Adults
NCT01274429
Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability
NCT01241942
Curcumin Biomarkers
NCT01333917
Perimenopausal Estrogen Replacement Therapy Study
NCT01308814
Tick-borne Illness and Clothing Study
NCT01454414
PRESENCE 2: Predicting Sedentary Entertainment Choices and Effects
NCT01523795
Omega-6 to Omega-3 Fatty Acid Ratio and Higher Order Cognitive Function in 7-to 9-year-olds
NCT01823419
Depression Treatment for Low Income Substance Users
NCT01189552
Discharge Planning for Elderly Patients in the Emergency Department: Use of a Brief Phone Call After Discharge to Improve Medication Utilization and Physician Follow-up
NCT01207180
Technology-Enhanced Helping the Noncompliant Child
NCT01367847
Gene Expression Variation and Implant Wound Healing Among Smokers and Diabetics
NCT01663298
Identifying Undiagnosed Asymptomatic HIV Infection in Hispanic/Latino Adolescents and Young Adults
NCT01203332
Oxytocin Treatment of Alcohol Withdrawal
NCT01212185
Treatment for Depression Among HIV-Infected Youth
NCT01049789
Can E-cadherin Found in Tissue/Blood be Valuable in Identifying & Monitoring Patients With Post-proton Pump Inhibitor (PPI)-Responsive Heartburn
NCT01149395
Pounds Off Digitally (POD): The Use of Podcasting and Mobile Media to Promote Weight Loss
NCT01139255
Effects of 2 Different Broccoli Sprout Containing Supplements on Nasal Cells in Healthy Volunteers
NCT01129466
Female Upper Genital Tract in HIV-infected Women
NCT02160392
CDC-ATN Linkage Evaluation
NCT02366533
Self Administration of Subcutaneous Depot Medroxyprogesterone Acetate
NCT00770887
Nitric Oxide Mediated Vasodilatory Response to Hawthorn Standardized Extract
NCT01331486
Tenofovir, Emtricitabine, Efavirenz and Atazanavir Pharmacokinetics in the Aging HIV-Infected Population
NCT01180075
Differences in Evoked Intracellular Interferon Signaling Pathways Using Single Cell Phosphoprotein Profiling
NCT01217359
ID & Testing in Male Partners
NCT01033812
Endothelial Cell Loss and Induced Astigmatism After Wound-directed and Wound-assisted IOL Injection
NCT01250964
Clopidogrel Pharmacogenomics Project
NCT01097343
Do Acid Sensing Ion Channels Contribute to Heartburn?
NCT01095133
A Representational Intervention to Promote Preparation for End-of-life Decision Making
NCT01259011
Development of an Empowerment Intervention for Young Women Living With HIV
NCT01454921
Topical Cyclosporine Suspension for the Treatment of Brittle Nails
NCT01064830
We Can Prevent Diabetes: A Behavioral Intervention to Reduce Diabetes Risk in African Americans
NCT01227473
Computerized HIV/Sexually Transmitted Disease (STD) Prevention Program
NCT00947947
Apremilast in the Treatment of Moderate to Severe Acne
NCT01074502
Preventative Misconception Intervention
NCT01049139
Fatty Acid Levels and Memory in Breastfed Children
NCT01942434
Sweet Preference and Alcohol Craving
NCT01296646
Efficacy of Retrograde Fill Vs Spontaneous Fill to Assess Voiding Function
NCT01091844
Dissemination of a Weight Management Program Among US Veterans
NCT00998452
Anticoagulation For Pulmonary Hypertension in Sickle Cell Disease
NCT01036802
Oxytocin Treatment of Schizophrenia
NCT01028677
Durability of Hypertonic Saline for Enhancing Mucociliary Clearance in Cystic Fibrosis
NCT01094704
Impact of Host Iron Status and Iron Supplement Use on Erythrocytic Stage of Plasmodium Falciparum
NCT01027663
Safety, Metabolism, and Antioxidant Activity of Silymarin and Green Tea Extract in Patients With Chronic Hepatitis C
NCT01018615
Cell Phone Reminders Intervention
NCT01049568
Intensive Computerized Brain Training (ICBT) in Youth With Early Onset Psychosis (EOP)
NCT01027962
Managerial Database II
NCT01009827
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 111 |
| Phase 2 | 92 |
| Phase 3 | 13 |
| Phase 4 | 56 |
Therapeutic Areas
What is open in the University of North Carolina, Chapel Hill pipeline
108 recruiting of 1,109 indexed (10% open); 881 completed (79%).
Phase mix: 69 late (III/IV) vs 203 early (I/II) (early-phase heavy).
Top condition: Obesity (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of North Carolina, Chapel Hill: open-pipeline peers nationwide
Peers matched on 1,109 registered trials and 10% open enrollment, not the therapeutic-area sidebar.
University of North Carolina, Chapel Hill sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,109 trials (± recruiting share)
- University of Florida · 1,106 trials · 15% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
Sponsors near 10% open enrollment (± trial volume)
- Children's Hospitals and Clinics of Minnesota · 10% recruiting · 31 trials
- Cytokinetics · 10% recruiting · 31 trials
- Sanofi · 10% recruiting · 713 trials
- Ohio University · 10% recruiting · 51 trials
Related
What to do with this University of North Carolina, Chapel Hill page
1,109 registered trials is a research-attention snapshot, not an endorsement of University of North Carolina, Chapel Hill or any single study.
- 108 of University of North Carolina, Chapel Hill's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of North Carolina, Chapel Hill studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of North Carolina, Chapel Hill pipeline card: 1,109 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.